Acute rhinosinusitis (ARS)

Written by

in

 

Rhinology: Acute Rhinosinusitis (ARS)

High-Yield Revision Notes for Board Review & PG Entrance Examinations

Acute Rhinosinusitis (ARS) is defined as sudden-onset inflammation of the nose and paranasal sinuses lasting less than 12 weeks. Because the nasal mucosa is invariably involved alongside the sinus mucosa, the term rhinosinusitis is preferred over sinusitis. Understanding how to clinically distinguish self-limiting viral etiologies from bacterial infections requiring antibiotics is a frequent board favorite.

1. Pathophysiology & Ostiomeatal Complex

The development of ARS typically hinges on a pathogenic triad: occlusion of sinus ostia, impairment of the ciliary clearance mechanism, and alteration of mucosal secretions.

  • Ostiomeatal Complex (OMC): Located in the middle meatus, this critical anatomical region represents the common final drainage pathway for the anterior sinuses: the maxillary sinus, anterior ethmoidal air cells, and frontal sinus. Edema or structural anomalies within the OMC lead to mucus stasis, hypoxia within the sinus cavity, and subsequent secondary bacterial proliferation.
  • Posterior Sinus Pathway: The posterior ethmoidal cells drain into the superior meatus, while the sphenoid sinus drains independently into the sphenoethmoidal recess.

2. Etiological Classification

The vast majority of ARS cases are initiated by viral upper respiratory tract infections (URIs). Secondary bacterial infection complicates only an estimated 0.5% to 2% of viral episodes.

  • Acute Viral Rhinosinusitis (AVRS / Common Cold): Typically caused by Rhinovirus, Coronavirus, Influenza, Parainfluenza, or Respiratory Syncytial Virus (RSV). Symptoms peak by day 3 and gradually decline, resolving completely within 7 to 10 days.
  • Acute Bacterial Rhinosinusitis (ABRS): Diagnosed when symptoms persist past 10 days or follow a severe trajectory. The most common bacterial pathogens isolated are:
    1. Streptococcus pneumoniae (Most common overall)
    2. Haemophilus influenzae (Non-typeable strains)
    3. Moraxella catarrhalis (Common in pediatric patients)

3. Clinical Diagnostic Criteria (IDSA / AAO-HNS)

The clinical diagnosis requires at least two major criteria, or one major plus two minor criteria. Note that purulent nasal discharge alone does not prove a bacterial origin, as viral infections can also cause discolored secretions.

Major Criteria Minor Criteria
• Purulent anterior nasal discharge or posterior nasal drip • Headache
• Nasal congestion/obstruction/blockage • Ear pain, pressure, or fullness
• Facial congestion, pain, pressure, or fullness (worse when bending forward) • Halitosis (foul breath)
• Hyposmia / Anosmia (decreased or absent smell) • Dental pain (maxillary sinus roots lie close to upper molars)
• Fever (present in acute phases) • Cough and Fatigue

Distinguishing ABRS from AVRS (“When to give antibiotics”)

According to international guidelines, an acute rhinosinusitis episode is highly likely to be bacterial if it matches any of these three clinical scenarios:

  1. Persistent Symptoms: Signs or symptoms last for ≥10 days without any evidence of clinical improvement.
  2. Severe Symptoms: High fever (≥102°F or 39°C) accompanied by purulent nasal discharge or intense facial pain for at least 3–4 consecutive days at the beginning of the illness.
  3. “Double-Sickening” (Worsening Trajectory): A patient initially starts recovering from a typical viral URI, but then abruptly develops new-onset high fever, increased nasal discharge, or worsening headache/facial pain around day 5 to 6.

4. Management Strategy

  • Symptomatic and Supportive Therapy (For both AVRS and ABRS): Analgesics/antipyretics (NSAIDs, Acetaminophen) for pain relief, saline nasal irrigations to liquefy thick secretions, and intranasal corticosteroids to decrease mucosal edema. Oral decongestants or short-term topical decongestants (e.g., Oxymetazoline for <3–5 days) help facilitate ostial drainage.
  • First-Line Empirical Antibiotic Choice (ABRS): Amoxicillin-Clavulanate (Augmentin) is favored over standard Amoxicillin due to the rising prevalence of beta-lactamase-producing H. influenzae and M. catarrhalis. The standard course is 5–7 days for adults.
  • Alternative for Penicillin Allergy: Doxycycline or a respiratory fluoroquinolone (e.g., Levofloxacin, Moxifloxacin). Macrolides are no longer recommended empirically due to high resistance rates in S. pneumoniae.

5. High-Yield Complications & Red Flags

Because the paranasal sinuses share thin bony walls with the orbit and skull base, uncontrolled bacterial infection can lead to critical emergencies:

Orbital Complications (Chandler Classification): Most commonly secondary to acute ethmoiditis breaching the lamina papyracea.

  • Stage I: Inflammatory collateral edema (Preseptal cellulitis) — vision and ocular motility are completely normal.
  • Stage II: Orbital cellulitis — diffuse infection of orbital fat, presenting with proptosis and chemosis.
  • Stage III: Subperiosteal abscess — pus collects between the lamina papyracea and periorbita, displacing the globe.
  • Stage IV: Orbital abscess — pus within the orbital tissues, leading to ophthalmoplegia and vision loss.
  • Stage V: Cavernous sinus thrombosis — bilateral extension, systemic toxicity, cranial nerve palsies (CN III, IV, V1, V2, VI).
  • Intracranial Complications: Breach of the posterior frontal sinus wall or cribriform plate can cause meningitis, epidural abscess, subdural empyema, or brain abscess.
  • Pott’s Puffy Tumor: A classic complication of acute frontal sinusitis presenting as osteomyelitis of the anterior table of the frontal bone, leading to a doughy, fluctuant swelling over the forehead.